Award
Delivery Order #SPE2DR26FDK4K
Delivery Order for Respiratory Medication Under Strategic Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$2,798.21
Ceiling
$2,798.21
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FDK4K
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) titled the Strategic Pharmaceutical Supply Contract. The recipient, AmerisourceBergen Drug Corp, is a leading pharmaceutical sourcing and distribution company specializing in supplying critical medications to federal healthcare systems. The contract procures the medication Spiriva Respimat, a respiratory inhalation treatment, signifying its role in supporting patient healthcare needs. The scope involves timely delivery of this specific pharmaceutical product within a short window in early 2026, ensuring availability in the federal supply chain. This order continues the longstanding strategic partnership established by the broader IDV that spans over a decade, emphasizing reliability and compliance with federal standards. While this delivery order was likely issued under existing competitive procurement mechanisms, no sole-source justification or additional subcontractor details are noted. Overall, this contract reinforces the agency's commitment to maintaining a steady and dependable supply of essential pharmaceuticals for public health.
Description
4571085943!SPIRIVA RESPIMAT 2.5 MCG INH 4GM